ARTHROTEC (G.D. Searle LLC Division of Pfizer Inc)
Welcome to the PulseAid listing for the ARTHROTEC drug offered from G.D. Searle LLC Division of Pfizer Inc. This Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Prostaglandin E1 Analog [EPC],Prostaglandins E, Synthetic [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | G.D. Searle LLC Division of Pfizer Inc |
NON-PROPRIETARY NAME: | diclofenac sodium and misoprostol |
SUBSTANCE NAME: | DICLOFENAC SODIUM; MISOPROSTOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Prostaglandin E1 Analog [EPC],Prostaglandins E, Synthetic [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1997-12-24 |
END MARKETING DATE: | 0000-00-00 |
ARTHROTEC HUMAN PRESCRIPTION DRUG Details:
Item Description | ARTHROTEC from G.D. Searle LLC Division of Pfizer Inc |
LABELER NAME: | G.D. Searle LLC Division of Pfizer Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50; 200(mg/1; ug/1) |
START MARKETING DATE: | 1997-12-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0025-1411_33928d44-f279-41ab-a3e9-210d78240f63 |
PRODUCT NDC: | 0025-1411 |
APPLICATION NUMBER: | NDA020607 |
Other DICLOFENAC SODIUM; MISOPROSTOL Pharmaceutical Manufacturers / Labelers: